Join us for an upcoming webinar on tumor fibrosis!
Nordic Bioscience A/S will be present at Keystone Symposia on Molecular and Cellular Biology 2023!
Nordic Bioscience digest of the Best of 2022 publication series
Madrigal met both primary endpoints in the Phase 3 MAESTRO-NASH clinical trial of Resmetirom
Nordic Bioscience's landmark collaboration study on PRO-C6 in NEJM Evidence has received two editorials.
Research published in NEJM Evidence positions Nordic Bioscience’s PRO-C6 as next-generation biomarker assay for trial enrichment in HFpEF
A multi-million deal in Denmark
Counterfeit versions of Nordic Bioscience's PRO-C3 biochemical assay have recently entered circulation globally.
Search and find publications that we have published.
Please don't hesitate to contact us if you have any questions or other inquiries.
